350 related articles for article (PubMed ID: 21609368)
1. Clinical implications of DNA methylation in hepatocellular carcinoma.
Sceusi EL; Loose DS; Wray CJ
HPB (Oxford); 2011 Jun; 13(6):369-76. PubMed ID: 21609368
[TBL] [Abstract][Full Text] [Related]
2. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.
Pogribny IP; Rusyn I
Cancer Lett; 2014 Jan; 342(2):223-30. PubMed ID: 22306342
[TBL] [Abstract][Full Text] [Related]
3. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
[TBL] [Abstract][Full Text] [Related]
4. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
[TBL] [Abstract][Full Text] [Related]
5. Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma.
Jain S; Chen S; Chang KC; Lin YJ; Hu CT; Boldbaatar B; Hamilton JP; Lin SY; Chang TT; Chen SH; Song W; Meltzer SJ; Block TM; Su YH
PLoS One; 2012; 7(4):e35789. PubMed ID: 22536438
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma.
Chu PY; Yeh CM; Hsu NC; Chang YS; Chang JG; Yeh KT
Swiss Med Wkly; 2010; 140():w13065. PubMed ID: 20648401
[TBL] [Abstract][Full Text] [Related]
8. CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma.
Zhang C; Guo X; Jiang G; Zhang L; Yang Y; Shen F; Wu M; Wei L
Int J Cancer; 2008 Sep; 123(5):998-1004. PubMed ID: 18546260
[TBL] [Abstract][Full Text] [Related]
9. [The Evaluation Value of Methylation Status of CpG Island of SFRP1 and LINE1 Gene Promoter Area in the Prognosis of Hepatocellular Carcinoma.].
Huang Y; Wei L; Sun AM; Zhao RC; Zhang J; Yang HT; Li B; Sun CJ; Ding XQ; Gao B; Zhong YQ; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):883-888. PubMed ID: 28598118
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor gene methylation in hepatocellular carcinoma.
Abdalla M; Khairy E; Louka ML; Ali-Labib R; Ibrahim EA
Gene; 2018 May; 653():65-71. PubMed ID: 29432829
[TBL] [Abstract][Full Text] [Related]
11. Review of genetic and epigenetic alterations in hepatocarcinogenesis.
Herath NI; Leggett BA; MacDonald GA
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):15-21. PubMed ID: 16706806
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.
Anwar SL; Lehmann U
World J Gastroenterol; 2014 Jun; 20(24):7894-913. PubMed ID: 24976726
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
14. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation markers in the detection of hepatocellular carcinoma.
Fu S; Debes JD; Boonstra A
Eur J Cancer; 2023 Sep; 191():112960. PubMed ID: 37473464
[TBL] [Abstract][Full Text] [Related]
16. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.
Lee S; Lee HJ; Kim JH; Lee HS; Jang JJ; Kang GH
Am J Pathol; 2003 Oct; 163(4):1371-8. PubMed ID: 14507645
[TBL] [Abstract][Full Text] [Related]
17. DNA Methylation Profiling of Human Hepatocarcinogenesis.
Hernandez-Meza G; von Felden J; Gonzalez-Kozlova EE; Garcia-Lezana T; Peix J; Portela A; Craig AJ; Sayols S; Schwartz M; Losic B; Mazzaferro V; Esteller M; Llovet JM; Villanueva A
Hepatology; 2021 Jul; 74(1):183-199. PubMed ID: 33237575
[TBL] [Abstract][Full Text] [Related]
18. DNA binding protein A expression and methylation status in hepatocellular carcinoma and the adjacent tissue.
Yasen M; Obulhasim G; Kajino K; Mogushi K; Mizushima H; Tanaka S; Tanaka H; Hino O; Arii S
Int J Oncol; 2012 Mar; 40(3):789-97. PubMed ID: 22159460
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.
Chappell G; Kutanzi K; Uehara T; Tryndyak V; Hong HH; Hoenerhoff M; Beland FA; Rusyn I; Pogribny IP
Int J Cancer; 2014 Jun; 134(12):2778-88. PubMed ID: 24242335
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
